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Abstract:

Cigarette and tobacco use is common among ED patients from lower socioeconomic
backgrounds. Our goal in this study was to conduct moderation and mediation analysis to
evaluate the effectiveness of an enhanced smoking cessation intervention involving enhanced
care as compared to standard care for adult smokers in the ED. Our study is a secondary analysis
of a two-arm randomized clinical trial conducted by Dr. Bernstein, which involved two
intervention arms; one with enhanced care where the subjects received a motivational interview
by a trained research assistant, 6 weeks of nicotine replacement therapy (NRT) initiated in the
ED, a faxed referral to the state smokers’ quitline, a booster call, and a brochure. The subjects in
control arm subjects received the brochure, which provided quitline information. We used
mediation analysis to assess the treatment effects of the mediators; NRT use and Quitline calls
and moderation analysis to evaluate the effect modification or interaction of the moderators;
baseline nicotine dependency and craving with the treatment. The outcomes were 7-day
abstinence and number of cigarettes smoked per day at three months. We found significant
mediation effects with the NRT use on both the outcomes. However, the speaking to a quitline
counselor had only marginal mediation effects. We could not detect any interaction or effect
modification with either of the two moderators on 7-day abstinence and no. of cigarettes smoked
per day.
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Background and Rationale:
Cigarette smoking and tobacco use is a global epidemic affecting about 1 billion people
worldwide and killing 6 million people per year (1). In the United States, one of the leading
causes of preventable deaths and related illnesses is cigarette use. According to U.S. Department
of Health and Human Services, more than 16 million Americans are currently living with a
disease attributable to smoking (2). In 2013, 17.8% (42.1 million) of all American adults aged
18 and above smoked and more than 480,000 died from smoking-related illnesses. The total
economic cost of smoking in the United States is more than $300 billion a year (3, 4).
The majority of smokers in the United States come from lower socioeconomic
backgrounds as compared to other populations. Poverty status, education and race/ethnicity
usually determine smoking behaviors in the United States. There is a wide gap between
socioeconomic status (SES) groups with respect to the use of tobacco products. Smoking
prevalence remains highest among those who have less than a high school education (28.4%),
those with no health insurance (28.6%), and those living below the federal poverty level (27.7%)
(5). To address these growing disparities, public policy efforts have been directed in order to
increase state Medicaid insurance coverage for evidence-based tobacco cessation treatments (6).
Currently, all the 50 states and the District of Columbia offer insurance coverage for tobacco
cessation treatment to Medicaid recipients (7), but the degree of coverage for services is different
in each state and these services are typically underutilized (8). Interventions delivered in health
care settings by physicians have the potential to reach a wide range of smokers, considering that
more than 70% of smokers see their physician each year. The Emergency Department (ED)
presents a unique opportunity for screening, intervention and referral for treatment, as these low
income populations commonly receive care in hospital emergency departments (ED), either for

6	
  
	
  

medical consequences of smoking or for comorbid medical and psychiatric conditions because
they often have limited access to primary care providers, who tend to undertreat tobacco use
(9,10, 11). Also, there is a greater prevalence of smoking in ED patients than in the general
population (12).
Tobacco control efforts have been taking place in ED settings for many years and a
recent meta-analysis of 7 ED studies containing 1,986 subjects found enhanced abstinence at one
month, with the odds for tobacco abstinence in the intervention arm (enhanced care; brochure,
motivational interview and nicotine patches) of 1.47 (95% CI 1.06-2.06), compared to controls
(usual care; just brochure) (13). Our study is based on Dr. Steven L Bernstein’s randomized
clinical trial where they studied the efficacy of an intervention incorporating Screening, Brief
Intervention, and Referral to Treatment with nicotine replacement therapy (SBIRT + NRT) and
quitline referral for adult smokers in an ED. In the study, the intervention subjects received a
motivational interview by a trained research assistant, 6 weeks of nicotine patches and gum
initiated in the ED, a faxed referral to the state smokers’ quitline, a booster call, and a brochure.
The controls received the brochure, which provided quitline information. The primary outcome
was biochemically confirmed tobacco abstinence at three months. The study showed that the
prevalence of biochemically confirmed abstinence was 12.2% (47/386) in the intervention arm
vs. 4.9% (19/388) in the control arm, for a difference in quit rates of 7.3% (95% CI 3.2%,
11.5%). In multivariable logistic modeling controlling for age, sex, and race/ethnicity, study
subjects remained more likely to be abstinent than controls (OR 2.72, 95% CI 1.55, 4.75).
The study utilized a multicomponent intervention model, so we wanted to determine which of
its individual components were responsible for any improvement compared to the control group.
Therefore, we planned to conduct a series of mediator analyses to observe the effects of these
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individual mechanisms. These results will be helpful in refining future the intervention for better
outcomes. A mediator is a variable that helps in identifying the mechanism or process that
underlies an observed relationship between an independent variable and a dependent variable.
We also planned to examine a few moderator analyses to determine the effectiveness of the
intervention in different subgroups of smokers. A moderator variable is a variable that affects the
direction and/or strength of the relation between an independent variable and a dependent
variable Past studies have shown that adherence with nicotine replacement therapy is associated
with both short-term (as short as 1-week) and long-term (6 months) smoking cessation treatment
outcome (14,15). We hypothesize that since the SBIRT + NRT intervention increases cessation
outcomes, NRT adherence is acting as a mediator between the treatment and outcome, hence the
participants may be more likely to report appropriate adherence with their NRT and
consequently better smoking cessation outcomes. Therefore, we planned to assess adherence
with NRT as a mediator. Since the intervention arm incorporated Quitline; we also hypothesized
that Quitline use will mediate the relationship between the intervention and smoking cessation
outcome, thereby improving the quitting rates. Hence, we plan to test Quitline use as a mediator.
Dr. Bernstein’s trial has hypothesized that the tobacco intervention may be more efficacious for
less nicotine-dependent participants. So, we wanted to examine whether baseline level of
nicotine dependency moderates the effect of treatment on the cessation outcome. In addition to
nicotine dependency, we hypothesize whether or not the level of craving (greater or lower),
measured at the time of discharge from the ED, is likely associated with less smoking and thus
more abstinence. Thus, we examined if the level of craving will moderate the effect of treatment
on smoking cessation outcome.
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Methods:
Study population
Our study is a secondary data analysis of the study conducted by Dr. Bernstein’s, which
was a single-hospital 2-arm randomized controlled trial of a multicomponent intervention for
adult smokers presenting to the ED, with blinded outcome assessment. The intervention arm
received a brief motivational interview, provision of six weeks of NRT, initiation of NRT in the
ED, active referral to a smokers’ quitline, a booster phone call 3 days after enrollment, and
provision of a smoking cessation brochure. The control arm received the brochure alone. The
study included patients who presented to the adult ED at Yale-New Haven Hospital (YNHH) and
their eligibility criteria were (1) 18 years or older (2) have smoked >= 100 cigarettes lifetime (3)
describe themselves as every or someday smokers (4) smoke at least 5 cigarettes/day (5) insured
by Medicaid or are uninsured, and (6) are able to give written informed consent. Dr. Bernstein’s
study had a sample size of 778 with 353 in each arm, based on 3-month of follow-up, a quit rate
in the intervention arm of 20%; in the control arm 12%, and an alpha at 2-sided 0.05 and 80%
power. Figure 1 illustrates flowchart of the selection and analysis process.
Outcomes, moderators, and mediators
Our outcomes are 7-day abstinence (dichotomous) and no. of cigarettes smoked per day
(continuous) at the 3 month follow-up timepoint.
We examined two mediators. Our first mediator is Quitline calls, which we divided into
two groups, have you spoken to a QT counselor (yes/no) or a continuous variable, total quitline
calls. Our second mediator is NRT use (continuous), which was evaluated either as total number
of single NRT used (NRTmax) or total number of combined NRT’s used (NRTcount).
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For our secondary data analysis, the moderators are baseline nicotine dependency and craving.
Statistical analysis
For the moderation analysis, we used SAS version 9.3. To perform moderation, we created an
interaction term to evaluate the two-way interactions of treatment with the moderators. We used
logistic regression for the dichotomous outcome and linear regression for the continuous
outcome. We have ran different models with individual variables in each model.
For the mediation analysis, we used SPSS Statistics Desktop software version 22.0 with the
process macro (16) for the continuous outcome and MPlus version 7.2 for the dichotomous
outcome. To perform mediation, we conducted a series of regression analyses to observe the
direct and indirect effect of the treatment on the outcomes. In the first step, we regressed the
exposure to outcome to show that the outcome is associated with the exposure. In the second
step, we regressed the mediator on the exposure to show that the mediator is associated with
exposure. In the next step, we regressed the mediator to the outcome but we included treatment
(intervention) in the model to account for the possibility that both the outcome and mediators are
caused by exposure. In the last step, we used the previous regression model to test how the effect
of exposure changes when the mediator is added to the model. We ran different mediation
models with a mediator in each model. We also ran a model with multiple mediators in the same
model but the results were not included in this study, since we observed the same mediation
effects as the individual model.
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Results:
The 778 subjects in this study were followed from October 2010 to December 2012. 774 (99.5%)
were alive at 3 months. The table 1 represents the baseline characteristics of study subjects,
which were comparable between treatment groups. More than half the study subjects were
nonwhite. Mean daily cigarette consumption was comparable between the two groups.
Table 1. Baseline patient characteristics.
Variable

Usual Care

Intervention

(N = 390)

(N = 388)

Age, mean, years

40.2

40.8

Sex, no. male (%)

201 (51.5%)

170 (43.8%)

White

157 (40.3%)

148 (38.1%)

African-American

153 (39.2)

155 (39.9)

Hispanic

77 (19.8)

81 (20.9)

Asian/Other

3 (0.8)

4 (1.1.)

Cigarettes/day, mean, SD

13.7 (SD = 7.4)

13.4 (SD = 8.1)

Race/ethnicity, N (%)

Below are the frequency tables describing the characteristics of the moderators (baseline nicotine
dependency and craving) and mediators (have you spoken to QT counsellor, total QT calls,
NRTcount and NRTmax)
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Table 2. Characteristics of mediators and moderators.
Variable

Usual Care

Intervention

(N = 390)

(N = 388)

NRTmax, mean, SD

5.5 (SD = 14.3)

24.1 (SD = 24.5)

NRTcount, mean, SD

2.75 (SD = 12.9)

32.8 (SD = 39.4)

Total Quitline Calls, mean, SD

0.31 (SD = 1.07)

0.52 (SD = 1.35)

Craving, mean, SD

4.64 (SD = 2.16)

4.77 (SD = 2.16)

Baseline Nicotine Dependency,

13.44 (SD = 8.19)

13.71 (SD = 7.47)

mean, SD

Table 3: Did you speak to QT counselor?
Frequency
Valid

Missing
Total

no
yes
Total
System

Percent

490
137
627
152

62.9
17.6
80.5
19.5

779

100.0

The total no. of cigarettes smoked per day before the trial was, on average, 13 for each group.
After the treatment, the no. of cigarettes smoked per day went down to, on average, 5 in the
SBIRT + NRT treatment group and 7.62 in the standard care group. Below are the statistics.
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Table 4: Cigarette smoking before and after Intervention
(N = 779)
Before Interventions
After Interventions
SBIRT
Standard
SBIRT
Standar
+ NRT
care
+ NRT
d care
13.44
13.71
5.01
7.62
Mean
8.19
7.47
6.00
6.89
Std.
Deviation

For the mediation, the total effect of the treatment on the 7-day abstinence was 0.098. The direct
and the indirect effects of the mediators are represented in table 5. Of the four mediators, total
QT calls (p=0.03) and NRTmax (p=0.006) significantly mediated the effect of treatment on the
outcome 7-day abstinence.
Table 5. Mediation effects on the 7-day abstinence outcome
Mediators

Total effect

Direct

Indirect

Significance

of

effect

effect (β)

(p-value)

treatment

(β)
0.088

0.009

p=0.069

9.2%

Total QT calls

0.083

0.014

P=0.03

14.3%

NRT count

0.097

0.000

p=0.987

0%

NRT max

0.053

0.044

p=0.006

44.9%

Spoken to QT
counselor?

Percentage mediated

0.098

*This is simple mediation analysis
For the outcome no. of cigarettes per day, the total effect of the treatment was 2.613. The direct
and the indirect effects of the mediators are represented in table 6. Of the four mediators, total
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NRTcount (p<0.001) and NRTmax (p<0.001) significantly mediated the effect of treatment on
the outcome no. of cigarettes per day.
Table 6. Mediation effects on the no. of cigarettes per day outcome
Mediators

Total effect

Direct

Indirect

Significance

Percentage

of treatment

effect (β)

effect (β)

(p-value)

mediated

2.499

0.113

p=0.097

4.3%

2.366

0.248

p=0.07

9.5%

NRT count

1.366

1.288

p<0.001

50.7%

NRT max

0.935

1.678

p<0.001

64%

Spoken to QT
counselor?
Total QT calls

2.613

*This is simple mediation analysis
The moderation analysis for the outcome no. of cigarettes per day, was conducted by creating an
interaction term between the treatment and the two moderators and a linear regression was
performed. The interaction term was not significant for either of the two moderators; baseline
dependency and craving. The test for fixed effects of treatment by baseline dependency levels 1,
2, 3 and craving on no. of cigarettes per day, resulted in an insignificant p-values. For the
outcome 7-day abstinence, the analysis of maximum likelihood estimates by baseline
dependency levels 1, 2, 3 and craving, also resulted in insignificant p values. Below are tables 7
and 8 showing the parameter estimates and p-values of the moderator analysis on the outcomes
no. of cigs per day and 7-day abstinence.
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Table 7. Test of fixed effects of moderators on no. of cigarettes/day.
Variable

Group

Estimate

Pr > |t|

Assignment
treatment*baselinedependency1

SBIRT + NRT

-1.3152

0.2112

treatment*baselinedependency2

SBIRT + NRT

-1.3563

0.4260

treatment*baselinedependency3

SBIRT + NRT

-2.4195

0.3529

craving*treatment

SBIRT + NRT

-0.4014

0.0939

Table 8. Analysis of Maximum Likelihood Estimates of moderators on 7-day abstinence.
Variable

Group

Estimate

Pr > |t|

Assignment
treatment*baselinedependency1

SBIRT + NRT

-0.0341

0.9449

treatment*baselinedependency2

SBIRT + NRT

-0.4409

0.6041

treatment*baselinedependency3

SBIRT + NRT

13.3825

0.9801

craving*treatment

SBIRT + NRT

-0.1008

0.3485
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Discussion and further implications
Our study has shown that at the end of a 3 month study period, nicotine replacement therapy
(NRT) has shown a significant mediation of the intervention on the 7-day abstinence and the no.
of cigarettes smoked per day. We have also observed that talking to a Quitline counselor has
shown some marginal mediation of the intervention on the 7-day abstinence and the no. of
cigarettes smoked per day. Craving and baseline dependency have not shown any moderation
effect on either of the two outcomes. The absence of moderation may be attributed to the fact
that the study had a low power to detect a statistical interaction between the moderators and the
treatment. Our study had a limitation that it was performed at a single site on low-income adult
population. Despite the fact that patients in this study were diverse with respect to race, ethnicity,
and gender, it is unclear whether the same results can be replicated in other patient populations.
So, it is not possible to generalize our results. Basing on these observations, further research
could be conducted that aim to increase the dosage of the NRT’s to improve the cessation rates.
Also, further studies can be conducted that can look at whether or not higher Quitline calls to the
patients on a regular basis improves the smoking cessation rates. Our outcome endpoint was 3
months. So, it would be interesting to look at the cessation rates over a longer period of time
(1yr, 2yrs, etc.) with the proposed interventions. Expanding and conducting trials in other patient
population could be useful to determine if similar interventions would yield the same results in
other populations too.
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Figure 1: Flow of patients through the trial

Assessed for eligibility (n= 29482)

Randomized (n= 780)

Standard Care
Allocated to intervention (n= 390)
• Received a brochure prepared by
the state Department of Public
Health that provides general
information about smoking
cessation.
• Phone number of the toll-free state
smokers’ quitline
3 Month – Standard Care (n= 390)
Deceased (n= 2)
Lost to follow-up (n= 75)

Intervention (SBIRT + NRT)
Allocated to intervention (n= 390)
• 10-15 minute brief motivational
interview.
• Six weeks of nicotine replacement
therapy (NRT)
•
A referral to the state Smokers’
Quitline.
• Phone call from the nurse three days
3 Month – SBIRT + NRT (n= 388)
Deceased (n= 2)
Lost to follow-up (n= 70)

Outcome – No. of cigs
per day and 7-day
abstinence at 3 mo.
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